Failure to generate bone marrow adipocytes does not protect mice from ovariectomy-induced osteopenia

Bone

Volumn 53, Issue 1, 2013, Pages 145-153

  Iwaniec, Urszula T ^a   Turner, Russell T ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Adipokines; Menopause; Osteoblast; Osteoclast; Osteoporosis

Indexed keywords

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BONE GROWTH; BONE MASS; BONE MINERALIZATION; BONE STRUCTURE; BONE TURNOVER; CELL DENSITY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; FEMALE; LUMBAR VERTEBRA; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOPENIA; OVARIECTOMY; PERIMETRY; TIBIA; TRABECULAR BONE;

ADIPOCYTES; ANIMALS; BONE DISEASES, METABOLIC; BONE MARROW CELLS; FEMALE; MICE; OVARIECTOMY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84871840852     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.11.034     Document Type: Article

References (64)

1. Devlin M.J. Why does starvation make bones fat?. Am J Hum Biol 2011, 23:577-585.
2. Duque G. Bone and fat connection in aging bone. Curr Opin Rheumatol 2008, 20:429-434.
3. Motyl K.J., Rosen C.J. Temperatures rising: brown fat and bone. Discov Med 2011, 11:179-185.
4. Sheu Y., Cauley J.A. The role of bone marrow and visceral fat on bone metabolism. Curr Osteoporos Rep 2011, 9:67-75.
5. Menagh P.J., Turner R.T., Jump D.B., Wong C.P., Lowry M.B., Yakar S., et al. Growth hormone regulates the balance between bone formation and bone marrow adiposity. J Bone Miner Res 2010, 25:757-768.
6. Bathija A., Davis S., Trubowitz S. Bone marrow adipose tissue: response to acute starvation. Am J Hematol 1979, 6:191-198.
7. Duque G., Li W., Adams M., Xu S., Phipps R. Effects of risedronate on bone marrow adipocytes in postmenopausal women. Osteoporos Int 2011, 22:1547-1553.
8. Jackson M.A., Iwaniec U.T., Turner R.T., Wronski T.J., Kalra S.P. Effects of increased hypothalamic leptin gene expression on ovariectomy-induced bone loss in rats. Peptides 2011, 32:1575-1580.
9. Maddalozzo G.F., Turner R.T., Edwards C.H., Howe K.S., Widrick J.J., Rosen C.J., et al. Alcohol alters whole body composition, inhibits bone formation, and increases bone marrow adiposity in rats. Osteoporos Int 2009, 20:1529-1538.
10. Martin R.B., Zissimos S.L. Relationships between marrow fat and bone turnover in ovariectomized and intact rats. Bone 1991, 12:123-131.
11. Morita Y., Iwamoto I., Mizuma N., Kuwahata T., Matsuo T., Yoshinaga M., et al. Precedence of the shift of body-fat distribution over the change in body composition after menopause. J Obstet Gynaecol Res 2006, 32:513-516.
12. Trudel G., Payne M., Madler B., Ramachandran N., Lecompte M., Wade C., et al. Bone marrow fat accumulation after 60 days of bed rest persisted 1 year after activities were resumed along with hemopoietic stimulation: the Women International Space Simulation for Exploration study. J Appl Physiol 2009, 107:540-548.
13. Kilroy G.E., Foster S.J., Wu X., Ruiz J., Sherwood S., Heifetz A., et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 2007, 212:702-709.
14. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
15. Akune T., Ohba S., Kamekura S., Yamaguchi M., Chung U.I., Kubota N., et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004, 113:846-855.
16. Cho S.W., Yang J.Y., Her S.J., Choi H.J., Jung J.Y., Sun H.J., et al. Osteoblast-targeted overexpression of PPARgamma inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice. J Bone Miner Res 2011, 26:1939-1952.
17. Grey A. Skeletal consequences of thiazolidinedione therapy. Osteoporos Int 2008, 19:129-137.
18. Turner R.T., Riggs B.L., Spelsberg T.C. Skeletal effects of estrogen. Endocr Rev 1994, 15:275-300.
19. Elbaz A., Rivas D., Duque G. Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL/6J mice. Biogerontology 2009, 10:747-755.
20. Kim Y.Y., Kim S.H., Oh S., Sul O.J., Lee H.Y., Kim H.J., et al. Increased fat due to estrogen deficiency induces bone loss by elevating monocyte chemoattractant protein-1 (MCP-1) production. Mol Cells 2010, 29:277-282.
21. Liu Y., Tang G.Y., Tang R.B., Peng Y.F., Li W. Assessment of bone marrow changes in postmenopausal women with varying bone densities: magnetic resonance spectroscopy and diffusion magnetic resonance imaging. Chin Med J (Engl) 2010, 123:1524-1527.
22. Martin R.B., Chow B.D., Lucas P.A. Bone marrow fat content in relation to bone remodeling and serum chemistry in intact and ovariectomized dogs. Calcif Tissue Int 1990, 46:189-194.
23. Sharp J.C., Copps J.C., Liu Q., Ryner L.N., Sebastian R.A., Zeng G.Q., et al. Analysis of ovariectomy and estrogen effects on body composition in rats by X-ray and magnetic resonance imaging techniques. J Bone Miner Res 2000, 15:138-146.
24. Turner R.T., Wong C.P., Iwaniec U.T. Effect of reduced c-Kit signaling on bone marrow adiposity. Anat Rec (Hoboken) 2011, 294:1126-1134.
25. Bagi C.M., Hanson N., Andresen C., Pero R., Lariviere R., Turner C.H., et al. The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA. Bone 2006, 38:136-144.
26. Thomsen J.S., Laib A., Koller B., Prohaska S., Mosekilde L., Gowin W. Stereological measures of trabecular bone structure: comparison of 3D micro computed tomography with 2D histological sections in human proximal tibial bone biopsies. J Microsc 2005, 218:171-179.
27. Iwaniec U.T., Wronski T.J., Turner R.T. Histological analysis of bone. Methods Mol Biol 2008, 447:325-341.
28. Miller S.C., Shupe J.G., Redd E.H., Miller M.A., Omura T.H. Changes in bone mineral and bone formation rates during pregnancy and lactation in rats. Bone 1986, 7:283-287.
29. Nicks K.M., Fowler T.W., Gaddy D. Reproductive hormones and bone. Curr Osteoporos Rep 2010, 8:60-67.
30. Benayahu D., Shur I., Ben-Eliyahu S. Hormonal changes affect the bone and bone marrow cells in a rat model. J Cell Biochem 2000, 79:407-415.
31. Qiu W., Andersen T.E., Bollerslev J., Mandrup S., Abdallah B.M., Kassem M. Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells. J Bone Miner Res 2007, 22:1720-1731.
32. Rosen C.J., Ackert-Bicknell C., Rodriguez J.P., Pino A.M. Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukaryot Gene Expr 2009, 19:109-124.
33. Somjen D., Katzburg S., Kohen F., Gayer B., Posner G.H., Yoles I., et al. The effects of native and synthetic estrogenic compounds as well as vitamin D less-calcemic analogs on adipocytes content in rat bone marrow. J Endocrinol Invest 2011, 34:106-110.
34. Songlin P., Ge Z., Yixin H., Xinluan W., Pingchung L., Kwoksui L., et al. Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on osteoporotic bone. Bone 2009, 45:534-544.
35. Sottile V., Seuwen K., Kneissel M. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone). Calcif Tissue Int 2004, 75:329-337.
36. Zhang H., Lu W., Zhao Y., Rong P., Cao R., Gu W., et al. Adipocytes derived from human bone marrow mesenchymal stem cells exert inhibitory effects on osteoblastogenesis. Curr Mol Med 2011, 11:489-502.
37. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010, 316:129-139.
38. Bartell S.M., Rayalam S., Ambati S., Gaddam D.R., Hartzell D.L., Hamrick M., et al. Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice. J Bone Miner Res 2011, 26:1710-1720.
39. Turner RT, Kalra SP, Wong CP, Philbrick KA, Lindenmaier LB, Boghossian S, Iwaniec UT. Peripheral leptin regulates bone formation. J Bone Miner Res. in press, [Epub ahead of print]. http://dx.doi.org/10.1002/jbmr.1734.
40. Wabitsch M., Braun S., Hauner H., Heinze E., Ilondo M.M., Shymko R., et al. Mitogenic and antiadipogenic properties of human growth hormone in differentiating human adipocyte precursor cells in primary culture. Pediatr Res 1996, 40:450-456.
41. Westerlind K.C., Wronski T.J., Ritman E.L., Luo Z.P., An K.N., Bell N.H., et al. Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain. Proc Natl Acad Sci U S A 1997, 94:4199-4204.
42. Turner R.T., Backup P., Sherman P.J., Hill E., Evans G.L., Spelsberg T.C. Mechanism of action of estrogen on intramembranous bone formation: regulation of osteoblast differentiation and activity. Endocrinology 1992, 131:883-889.
43. Turner R.T., Hannon K.S., Demers L.M., Buchanan J., Bell N.H. Differential effects of gonadal function on bone histomorphometry in male and female rats. J Bone Miner Res 1989, 4:557-563.
44. Hatanaka K., Tanishita H., Ishibashi-Ueda H., Yamamoto A. Hyperlipidemia in mast cell-deficient W/WV mice. Biochim Biophys Acta 1986, 878:440-445.
45. Potter J.E., Wright E.G. Bone marrow lipids in normal and anemic mice. Am J Hematol 1980, 8:361-367.
46. Altintas M.M., Nayer B., Walford E.C., Johnson K.B., Gaidosh G., Reiser J., et al. Leptin deficiency-induced obesity affects the density of mast cells in abdominal fat depots and lymph nodes in mice. Lipids Health Dis 2011, 11:21.
47. Wang J., Shi G.P. Mast cell stabilization: novel medication for obesity and diabetes. Diabetes Metab Res Rev 2011, 27:919-924.
48. Agostino N.M., Chinchilli V.M., Lynch C.J., Koszyk-Szewczyk A., Gingrich R., Sivik J., et al. Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice. J Oncol Pharm Pract 2012, 17:197-202.
49. Hagerkvist R., Jansson L., Welsh N. Imatinib mesylate improves insulin sensitivity and glucose disposal rates in rats fed a high-fat diet. Clin Sci (Lond) 2008, 114:65-71.
50. Miettinen M., Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 2005, 13:205-220.
51. Zsebo K.M., Williams D.A., Geissler E.N., Broudy V.C., Martin F.H., Atkins H.L., et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990, 63:213-224.
52. Lotinun S., Evans G.L., Turner R.T., Oursler M.J. Deletion of membrane-bound steel factor results in osteopenia in mice. J Bone Miner Res 2005, 20:644-652.
53. Somerville J.M., Aspden R.M., Armour K.E., Armour K.J., Reid D.M. Growth of C57BL/6 mice and the material and mechanical properties of cortical bone from the tibia. Calcif Tissue Int 2004, 74:469-475.
54. Kuroda H., Terada N., Nakayama H., Matsumoto K., Kitamura Y. Infertility due to growth arrest of ovarian follicles in Sl/Slt mice. Dev Biol 1988, 126:71-79.
55. Nakano T., Waki N., Yoshiyasu S., Kanamaru A., Kitamura Y. The cause of anemia in mutant mice of Sl/Slt genotype: hypoplasia in bone marrow and restricted hyperplasia in spleen. Exp Hematol 1988, 16:117-121.
56. Lotinun S., Sibonga J.D., Turner R.T. Triazolopyrimidine (trapidil), a platelet-derived growth factor antagonist, inhibits parathyroid bone disease in an animal model for chronic hyperparathyroidism. Endocrinology 2003, 144:2000-2007.
57. Puri N., Roche P.A. Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Natl Acad Sci U S A 2008, 105:2580-2585.
58. Brumsen C., Papapoulos S.E., Lentjes E.G., Kluin P.M., Hamdy N.A. A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men. Bone 2002, 31:556-561.
59. Chiappetta N., Gruber B. The role of mast cells in osteoporosis. Semin Arthritis Rheum 2006, 36:32-36.
60. Kim M.S., Chae H.J., Shin T.Y., Kim H.M., Kim H.R. Estrogen regulates cytokine release in human mast cells. Immunopharmacol Immunotoxicol 2001, 23:495-504.
61. Rossini M., Zanotti R., Bonadonna P., Artuso A., Caruso B., Schena D., et al. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. Bone 2011, 49:880-885.
62. van der Veer E., van der Goot W., de Monchy J.G., Kluin-Nelemans H.C., van Doormaal J.J. High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis. Allergy 2012, 67:431-438.
63. Lesclous P., Saffar J.L. Mast cells accumulate in rat bone marrow after ovariectomy. Cells Tissues Organs 1999, 164:23-29.
64. Turner R.T., Iwaniec U.T., Marley K., Sibonga J.D. The role of mast cells in parathyroid bone disease. J Bone Miner Res 2010, 25:1637-1649.